We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » Wyeth Taps EDC for 80% of Its Clinical Trials; Reports Significant Benefits
Wyeth Taps EDC for 80% of Its Clinical Trials; Reports Significant Benefits
March 22, 2006
Pharma giant Wyeth is now using electronic data capture (EDC) in roughly 80 percent of its clinical trials -- with a goal of 90 percent by the end of 2007, according to a company project leader.